ArticleScientific reports2026

Synergistic effects of HDAC inhibitor tucidinostat and ENT inhibitor dipyridamole in T-cell malignancies.

Jiazhou Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.